Clinical Trial Update: A Multi-centre Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip Replacement [Phase 4]

View source ↗

Summary

A multi-centre Phase 4 study evaluating the long-term performance of the DePuy PROXIMA Hip in primary total hip replacement has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis
• Developmental Dysplasia of the Hip
• Femoral Fractures
• Osteoarthritis
• Post-traumatic Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• PROXIMA Hip

Snippet

Sponsor: DePuy International | Conditions: Rheumatoid Arthritis, Osteoarthritis | Phase 4 | Status: TERMINATED